Andy Vendel is a Senior Director in Immunology at Eli Lilly and Company, where they have served since 2022. Prior to this role, they held positions as Director and Senior Scientist in Immunology at the same company. Andy's experience includes leading scientific teams on various preclinical and clinical projects, as well as serving as Chair of the mentoring committee for The Protein Society from 2011 to 2015. They earned a Ph.D. in Biochemistry and Molecular Biology from Colorado State University, where they also conducted research as a Graduate Student and Postdoc.
This person is not in any teams
This person is not in any offices